Back to Search
Start Over
818P Veliparib with carboplatin and paclitaxel in frontline high-grade serous ovarian cancer (HGSOC): Efficacy and safety of paclitaxel weekly and every 3 weeks in the VELIA study.
- Source :
-
Annals of Oncology . 2020 Supplement 4, Vol. 31, pS618-S618. 1p. - Publication Year :
- 2020
- Subjects :
- *OVARIAN cancer
*PACLITAXEL
*CARBOPLATIN
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 31
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152695492
- Full Text :
- https://doi.org/10.1016/j.annonc.2020.08.957